Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease

NCT01842841 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher Disease

Interventions

DRUG: velaglucerase alfa

Sponsor

Shire

Collaborators

[object Object]